1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Johnson, B.A. Stevens, S.P. Williamson, J.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 33 15061 15070 10.1021/bi00254a015 7999764 Determination of the three-dimensional structure of margatoxin by 1H, 13C, 15N triple-resonance nuclear magnetic resonance spectroscopy. 1994 10.2210/pdb1mtx/pdb pdb_00001mtx 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4192.048 MARGATOXIN 1 nat polymer no no TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Centruroides sample 29018 Centruroides margaritatus database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1995-11-14 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1994-12-27 REL 23 BRUNGER refinement X-PLOR THR 1 n 1 THR 1 A ILE 2 n 2 ILE 2 A ILE 3 n 3 ILE 3 A ASN 4 n 4 ASN 4 A VAL 5 n 5 VAL 5 A LYS 6 n 6 LYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A PRO 10 n 10 PRO 10 A LYS 11 n 11 LYS 11 A GLN 12 n 12 GLN 12 A CYS 13 n 13 CYS 13 A LEU 14 n 14 LEU 14 A PRO 15 n 15 PRO 15 A PRO 16 n 16 PRO 16 A CYS 17 n 17 CYS 17 A LYS 18 n 18 LYS 18 A ALA 19 n 19 ALA 19 A GLN 20 n 20 GLN 20 A PHE 21 n 21 PHE 21 A GLY 22 n 22 GLY 22 A GLN 23 n 23 GLN 23 A SER 24 n 24 SER 24 A ALA 25 n 25 ALA 25 A GLY 26 n 26 GLY 26 A ALA 27 n 27 ALA 27 A LYS 28 n 28 LYS 28 A CYS 29 n 29 CYS 29 A MET 30 n 30 MET 30 A ASN 31 n 31 ASN 31 A GLY 32 n 32 GLY 32 A LYS 33 n 33 LYS 33 A CYS 34 n 34 CYS 34 A LYS 35 n 35 LYS 35 A CYS 36 n 36 CYS 36 A TYR 37 n 37 TYR 37 A PRO 38 n 38 PRO 38 A HIS 39 n 39 HIS 39 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O GLY 26 A O GLY 26 A N TYR 37 A N TYR 37 1 A ASN 4 -88.40 31.93 1 A ASN 31 4.82 65.65 2 A ASN 4 -113.75 56.94 2 A ALA 19 -87.11 33.22 2 A GLN 20 -131.81 -61.18 2 A ASN 31 4.81 65.84 3 A ASN 4 -111.08 78.98 3 A ASN 31 4.66 66.56 4 A GLN 20 -106.88 -62.94 4 A LYS 28 -119.05 -168.30 4 A MET 30 -95.18 -141.38 4 A ASN 31 -38.43 -30.31 5 A GLN 20 -106.90 -61.37 5 A ASN 31 4.89 65.98 5 A PRO 38 -59.92 107.69 6 A ASN 31 4.99 65.82 7 A ASN 4 -112.18 66.85 7 A PHE 21 -96.65 -65.35 7 A MET 30 -154.31 40.28 7 A ASN 31 179.87 39.73 8 A ASN 31 4.77 65.89 9 A ASN 4 -105.07 78.44 9 A ASN 31 5.05 65.71 10 A ASN 4 -85.41 49.01 10 A ASN 31 4.76 65.81 11 A GLN 20 -137.36 -55.64 11 A MET 30 -85.38 -140.07 12 A GLN 20 -109.26 -64.96 12 A ASN 31 4.82 65.54 13 A GLN 20 -125.78 -57.03 13 A ASN 31 4.86 65.67 13 A PRO 38 -60.99 90.61 14 A LYS 28 -123.10 -168.92 14 A MET 30 -84.56 -140.29 15 A ASN 4 -109.45 76.20 15 A GLN 20 -120.13 -54.65 15 A MET 30 -155.39 28.86 15 A ASN 31 -167.53 43.43 16 A GLN 20 -104.47 -61.70 16 A MET 30 -84.72 -103.78 17 A ASN 4 -110.80 65.74 17 A GLN 20 -126.65 -57.27 17 A LYS 28 -126.39 -168.21 17 A MET 30 -84.72 -143.02 18 A GLN 20 -93.93 -61.86 18 A MET 30 -98.52 -135.58 18 A ASN 31 -35.28 -31.22 19 A ASN 4 -103.22 77.30 19 A ASN 31 4.93 66.13 20 A ASN 4 -105.25 78.78 20 A ASN 31 4.60 66.06 21 A ASN 4 -109.45 69.48 21 A MET 30 -84.67 -140.77 22 A GLN 20 -123.07 -55.87 22 A ASN 31 4.99 65.62 22 A PRO 38 -59.90 105.71 23 A GLN 20 -121.97 -56.35 23 A ASN 31 4.88 65.82 23 A PRO 38 -59.11 108.26 model building X-PLOR refinement X-PLOR phasing X-PLOR DETERMINATION OF THE THREE-DIMENSIONAL STRUCTURE OF MARGATOXIN BY 1H, 13C, 15N TRIPLE-RESONANCE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1 Y N A PRO 10 A PRO 10 HELX_P A GLN 20 A GLN 20 5 1 11 disulf 2.020 A CYS 7 A SG CYS 7 1_555 A CYS 29 A SG CYS 29 1_555 disulf 2.020 A CYS 13 A SG CYS 13 1_555 A CYS 34 A SG CYS 34 1_555 disulf 2.022 A CYS 17 A SG CYS 17 1_555 A CYS 36 A SG CYS 36 1_555 TOXIN TOXIN SCKM_CENMA UNP 1 1 P40755 TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH 1 39 1MTX 1 39 P40755 A 1 1 39 2 anti-parallel A GLY 26 A GLY 26 A MET 30 A MET 30 A LYS 33 A LYS 33 A TYR 37 A TYR 37 1 P 1